SCI Pharmtech, Inc. (TPE:4119)
Taiwan · Delayed Price · Currency is TWD 48.60
-0.95 (-1.92%)
Jul 30, 2026, 11:25 AM CST
SCI Pharmtech Market Cap
SCI Pharmtech has a market cap or net worth of 5.92 billion as of July 29, 2026. Its market cap has decreased by -16.72% in one year.
Market Cap
5.92B
Enterprise Value
6.96B
Revenue
1.36B
Ranking
n/a
PE Ratio
61.85
Stock Price
48.60
ChartMarket Cap Chart
Since January 5, 2004, SCI Pharmtech's market cap has increased from 1.06B to 5.92B, an increase of 456.15%. That is a compound annual growth rate of 7.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 5.92B | 1.75% |
| Dec 31, 2025 | 5.82B | -46.25% |
| Dec 31, 2024 | 10.83B | -6.40% |
| Dec 29, 2023 | 11.57B | 24.39% |
| Dec 30, 2022 | 9.30B | 16.07% |
| Dec 30, 2021 | 8.01B | 20.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Foresee Pharmaceuticals | 12.71B |
| Standard Chemical & Pharmaceutical | 11.26B |
| Alar Pharmaceuticals | 7.05B |
| Formosa Laboratories | 6.21B |
| Orient Pharma | 5.70B |
| Panion & Bf Biotech | 5.12B |
| Easywell Biomedicals | 4.41B |
| LIWANLI Innovation | 4.08B |